![Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator | BMC Surgery | Full Text Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator | BMC Surgery | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12893-022-01628-6/MediaObjects/12893_2022_1628_Fig1_HTML.png)
Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator | BMC Surgery | Full Text
![Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases - ecancer Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases - ecancer](https://ecancer.org/en/journal/article/site/data/images/article/784/can-11-779fig5.gif)
Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases - ecancer
![Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results](https://f6publishing.blob.core.windows.net/1f222ac9-964e-46a4-af57-43f89f889b4f/WJCC-9-4559-g004.png)
Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
ASCO GU 2020: A Novel Clinical Decision Aid to Support Personalized Treatment Selection for Patients with cT1 Renal Cortical Masses: Results from A Multi-Institutional Competing Risks Analysis Including Performance Status and Comorbidity
![Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation | BMC Medical Informatics and Decision Making | Full Text Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation | BMC Medical Informatics and Decision Making | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6947-13-72/MediaObjects/12911_2013_Article_692_Fig1_HTML.jpg)
Appraisal of the Karnofsky Performance Status and proposal of a simple algorithmic system for its evaluation | BMC Medical Informatics and Decision Making | Full Text
![Systematic Assessment of the Patient With Cancer and Consequences of Treatment - BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY - Handbook of Cancer Chemotherapy (Lippincott Williams & Wilkins Systematic Assessment of the Patient With Cancer and Consequences of Treatment - BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY - Handbook of Cancer Chemotherapy (Lippincott Williams & Wilkins](https://doctorlib.info/oncology/handbook-cancer-chemotherapy/handbook-cancer-chemotherapy.files/image018.jpg)
Systematic Assessment of the Patient With Cancer and Consequences of Treatment - BASIC PRINCIPLES AND CONSIDERATIONS OF RATIONAL CHEMOTHERAPY AND MOLECULAR TARGETED THERAPY - Handbook of Cancer Chemotherapy (Lippincott Williams & Wilkins
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/4-Table2-1.png)